1. Intraoral Myeloid sarcoma with bilateral involvement: Case report
- Author
-
Dimitrios Andreadis, Fotios Iordanidis, Athanasios Poulopoulos, and Konstantinos D. Antoniadis
- Subjects
Marketing ,medicine.medical_specialty ,business.industry ,Strategy and Management ,chloroma ,RK1-715 ,030206 dentistry ,medicine.disease ,Dermatology ,granulocytic sarcoma ,03 medical and health sciences ,0302 clinical medicine ,hemic and lymphatic diseases ,Dentistry ,030220 oncology & carcinogenesis ,myeloid sarcoma ,Media Technology ,medicine ,Myeloid sarcoma ,acute myeloid leukaemia ,General Materials Science ,business ,oral tumours - Abstract
Background: Myeloid sarcoma (MS) is a solid malignant tumour associated with infiltration of immature myeloid precursor cells in an extramedullary site. The term MS has replaced the term granulocytic sarcoma and chloroma, which were used in the past. MS in the oral cavity is very uncommon, with less of 40 cases reported until recently. Case Report: We report the first case, the features, and the diagnostic sequence, of intraoral MS with bilateral palatal involvement, which presented as an initial manifestation, and preceded the appearance of acute myeloid leukemia (AML). Diagnostic confirmation of such oral mucosal lesions usually requires biopsy, histopathological examination with additional immunohistochemical investigation. MS can occur during the course of acute or chronic myelogenous leukemia, and myelodysplastic syndromes. In the vast majority of the reported cases, only one site was involved with a single intraoral MS lesion, and the cases predominantly associated with AML. Conclusion: The majority of intraoral MS occurs in patients with known AML, but in some of them, presented as an initial manifestation, and preceded the appearance of the disease. Therefore, clinicians should carefully evaluate all unusual oral lesions of unknown origin.
- Published
- 2017
- Full Text
- View/download PDF